Home
/ Agenus
/ Competitors

Agenus Competitors and Similar CompaniesClear all

Lyell's competitors and similar companies include Halozyme Therapeutics and AstraZeneca.

	Lyell Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.	Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.	AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
Founding Date	Founding Date 2018	Founding Date 1998	Founding Date 1999
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech oncology platform therapy	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma
Locations	Locations South San Francisco, US HQ Bothell, US Seattle, US	Locations San Diego, US HQ	Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more
Employees	Employees 188	Employees 373157% increase	Employees 94,300
Valuation ($)	Valuation ($) 243.3 m	Valuation ($) 6.4 b	Valuation ($) 2.7 b
Financial
Revenue (est.)	Revenue (est.) $36k (FY, 2025)	Revenue (est.) $1.4b (FY, 2025)	Revenue (est.) $58.7b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods $228.8m (FY, 2025)	Cost of goods $4.9b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit $1.2b (FY, 2025)	Gross profit $54.2b (FY, 2025)
Net income	Net income ($274.4m) (FY, 2025)	Net income $316.9m (FY, 2025)	Net income $10.2b (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 171.9m	Total funding raised $ 1b